Autres langues Journey Medical Corporation

Actions

DERM

US48115J1097

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
3,54 ^USD	0,00 %		-6,84 %	-38,54 %

21/03	Transcript : Journey Medical Corporation, 2023 Earnings Call, Mar 21, 2024
21/03	Journey Medical Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights	21/03
Journey Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	18/03
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea	18/03
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024	15/03
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference	13/03
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting	11/03
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 on Microbial Flora of Healthy Adults At 2024 Annual Meeting	11/03
Journey Medical Submits New Drug Application to FDA for Rosacea Treatment; Shares Rise	05/01
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	05/01
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea	05/01
Journey Medical Signs Credit Facility of up to $20 Million	02/01
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million	02/01
Journey Medical Corporation Secures Credit Facility with SWK Holdings for Up to $20 Million	02/01
Journey Medical Corporation Announces Resignation of Jeffrey Paley as Member of the Board of Directors	08/12
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea	06/12
Journey Medical Corporation Announces Successful Completion of Pre-Nda Meeting with the Fda for Dfd-29 to Treat Rosacea	06/12
Journey Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $34.5M	07/11
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Posts Q3 EPS $0.99	07/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Journey Medical Corporation

Actions

DERM

US48115J1097

Autres langues

Filtres